Public research preview

Undisclosed SIX management transaction party T1Q8J000C6, A non-executive member of the board of directors of Basilea Pharmaceutica AG, Allschwil

Disclosed a sell transaction in Basilea Pharmaceutica AG, Allschwil. Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Stadig frisk
100/100
Signalkvalitet
46/100
Datakvalitet
91%
Høj kvalitet

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
SIX management transactions
Published
19 Aug 2026, 00:00
Parser confidence
96%
Instrument mapping
85%
Filing delay
0 days

Tidslinje

Transaktionsdato

19 Aug 2026

Offentliggørelse

19 Aug 2026

Nu

Sporet i dag

Indberetningsforsinkelse: 0 dage

Kursbevægelse

Komplet dækning

Udbyder
EODHD global daily close
Hentet
21. aug. 2026

Kursforløb

BSLN fra kontekst før transaktionen til seneste lukkekurs.

Transaktion

19. aug. 2026 · 62,5 CHF · Ville ikke købe

Systemets beslutning

Ville ikke købeStrategiens filtre afviser dette signal. Fejlede filtre: Buy disclosure · 20-trading-day benchmark-relative pre-disclosure move <= 5pp.

Endnu ikke offentlig48,656,664,5CHFDato10. jun.19. aug.20. aug.Officiel offentliggørelse19. aug.TransaktionSeneste
  • Endnu ikke offentlig
  • Ville ikke købe
Observeret luk ved transaktion
62,5
Observeret luk ved offentliggørelse
62,5
Observeret seneste luk
64,5
Bevægelse før indberetning
0,0 %
Bevægelse efter indberetning
+3,2 %
Markedsjusteret bevægelse
+3,3 %
1w since disclosure
1m since disclosure
3m since disclosure
Topstigning før indberetning
Tilbagetrækning fra top

Why Copy Window is Still fresh

Supporting factors

  • Parsed sell disclosure for ordinary shares from SIX management transactions.
  • Transaction value is CHF 141,731.
  • Post-disclosure move is calculated from EODHD global daily close daily closes.

Cautions

  • EODHD global daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

SIX management transactions, published 19 Aug 2026, 00:00

View source
Parser confidence
96%
Instrument mapping
85%
FieldExtracted value
isinCH0011432447
roleA non-executive member of the board of directors
sidesell
value141730.65
sourcesix_management_transactions
volume2401
currencyCHF
assetTypestock
sourceUrlhttps://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q8J000C6
personNameUndisclosed SIX management transaction party T1Q8J000C6
companyNameBasilea Pharmaceutica AG, Allschwil
publishedAt2026-08-19T00:00:00.000Z
rawDocumentIdraw-ch-six-c1722dce929a
disclosureDate2026-08-19
transactionDate2026-08-19